CN101778858B - 大环内酯固态晶型 - Google Patents

大环内酯固态晶型 Download PDF

Info

Publication number
CN101778858B
CN101778858B CN2008801005518A CN200880100551A CN101778858B CN 101778858 B CN101778858 B CN 101778858B CN 2008801005518 A CN2008801005518 A CN 2008801005518A CN 200880100551 A CN200880100551 A CN 200880100551A CN 101778858 B CN101778858 B CN 101778858B
Authority
CN
China
Prior art keywords
polymorphic
dipiperidinyl
mycaminosyl
tylonolide
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2008801005518A
Other languages
English (en)
Chinese (zh)
Other versions
CN101778858A (zh
Inventor
F·布拉特尔
M·布伦纳
G·胡
T·拉赫尔
R·瓦拉斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Intervet International BV
Original Assignee
Microbial Chemistry Research Foundation
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation, Intervet International BV filed Critical Microbial Chemistry Research Foundation
Priority to CN201310279877.4A priority Critical patent/CN103360445B/zh
Priority to CN201310280228.6A priority patent/CN103360446B/zh
Priority to CN201310280229.0A priority patent/CN103360447B/zh
Publication of CN101778858A publication Critical patent/CN101778858A/zh
Application granted granted Critical
Publication of CN101778858B publication Critical patent/CN101778858B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
CN2008801005518A 2007-07-26 2008-07-25 大环内酯固态晶型 Active CN101778858B (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201310279877.4A CN103360445B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310280228.6A CN103360446B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310280229.0A CN103360447B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07113244A EP2019112A1 (en) 2007-07-26 2007-07-26 Macrolide solid-state forms
EP07113244.3 2007-07-26
PCT/EP2008/059775 WO2009013351A2 (en) 2007-07-26 2008-07-25 Macrolide solid-state forms

Related Child Applications (4)

Application Number Title Priority Date Filing Date
CN201310280229.0A Division CN103360447B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310279877.4A Division CN103360445B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN2013102805250A Division CN103467548A (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310280228.6A Division CN103360446B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型

Publications (2)

Publication Number Publication Date
CN101778858A CN101778858A (zh) 2010-07-14
CN101778858B true CN101778858B (zh) 2013-12-04

Family

ID=39467287

Family Applications (5)

Application Number Title Priority Date Filing Date
CN2008801005518A Active CN101778858B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310280228.6A Active CN103360446B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310279877.4A Active CN103360445B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN2013102805250A Pending CN103467548A (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310280229.0A Active CN103360447B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型

Family Applications After (4)

Application Number Title Priority Date Filing Date
CN201310280228.6A Active CN103360446B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310279877.4A Active CN103360445B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN2013102805250A Pending CN103467548A (zh) 2007-07-26 2008-07-25 大环内酯固态晶型
CN201310280229.0A Active CN103360447B (zh) 2007-07-26 2008-07-25 大环内酯固态晶型

Country Status (13)

Country Link
EP (3) EP2019112A1 (pt)
JP (7) JP5925989B2 (pt)
KR (2) KR20160003899A (pt)
CN (5) CN101778858B (pt)
AU (1) AU2008278969B8 (pt)
BR (1) BRPI0814318B1 (pt)
CA (1) CA2693801C (pt)
ES (2) ES2608978T3 (pt)
HU (1) HUE031449T2 (pt)
RU (1) RU2476438C2 (pt)
TW (1) TWI427083B (pt)
WO (1) WO2009013351A2 (pt)
ZA (1) ZA201000188B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2089408T3 (pl) 2006-07-28 2012-03-30 Intervet Int Bv Sposób syntezy makrolidu
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
CA2856708C (en) 2011-11-25 2022-01-11 Bayer Intellectual Property Gmbh Antibacterial tylosin derivatives and methods for their preparation
CN102816196A (zh) * 2012-09-10 2012-12-12 河北远征药业有限公司 泰地罗新半抗原、人工抗原及其制备方法
PL2999707T3 (pl) * 2013-05-23 2018-09-28 Bayer Animal Health Gmbh Pochodne tylozynowe i sposób ich wytwarzania
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104774223A (zh) * 2015-03-26 2015-07-15 宁夏泰瑞制药股份有限公司 一种利用泰乐菌素碱生产泰地罗新的方法
CN105254693B (zh) * 2015-11-13 2017-12-22 周金华 一种泰地罗新的合成方法
CN106046084B (zh) * 2016-06-02 2019-08-09 天津大学 泰地罗新丙酮溶剂化合物及制备方法
CN106083958B (zh) * 2016-06-02 2019-07-23 天津大学 泰地罗新环己烷溶剂化合物及制备方法
CN106008629B (zh) * 2016-06-02 2019-11-22 天津大学 泰地罗新1,4-二氧六环溶剂化合物及制备方法
CN109721633A (zh) * 2017-10-31 2019-05-07 齐鲁晟华制药有限公司 一种泰地罗新晶型a及其制备方法
CN111349130A (zh) * 2018-12-21 2020-06-30 齐鲁动物保健品有限公司 一种泰地罗新晶型b及其制备方法
CA3202396A1 (en) 2020-12-03 2022-06-09 Intervet International B.V. A method of treating foot rot
CN114213484A (zh) * 2021-12-21 2022-03-22 河北远征药业有限公司 一种泰地罗新1，2-丙二醇溶剂化合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514946B1 (en) * 1999-08-30 2003-02-04 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Macrolide antibiotics and treatment and prophylaxis of pasteurellosis using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL33732A (en) * 1969-02-06 1973-05-31 Meiji Seika Kaisha The new antibiotics sf-837,sf-837-a2,sf-837-a3 and sf-837-a4 and their production
AU561147B2 (en) 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
US4820695A (en) 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
YU43658B (en) * 1983-07-18 1989-10-31 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
EP2772254A3 (en) * 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
WO2005019226A1 (en) * 2003-08-26 2005-03-03 Biocon Limited A process for the recovery of substantially pure tricyclic macrolide
WO2006083486A1 (en) * 2005-01-05 2006-08-10 TEVA GYÓGYSZERGYÁR ZÁRTKöR..EN M..k..D.. RÉSZVÉNYTÁRSASÁG Amorphous tacrolimus and preparation thereof
PL2089408T3 (pl) * 2006-07-28 2012-03-30 Intervet Int Bv Sposób syntezy makrolidu
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514946B1 (en) * 1999-08-30 2003-02-04 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Macrolide antibiotics and treatment and prophylaxis of pasteurellosis using the same

Also Published As

Publication number Publication date
AU2008278969B8 (en) 2012-03-15
CN103360447B (zh) 2016-04-06
ES2608978T3 (es) 2017-04-17
CN103360445A (zh) 2013-10-23
CA2693801A1 (en) 2009-01-29
EP2019112A1 (en) 2009-01-28
KR20100044864A (ko) 2010-04-30
CN103360446B (zh) 2016-04-06
JP2020172517A (ja) 2020-10-22
WO2009013351A2 (en) 2009-01-29
EP3170833A1 (en) 2017-05-24
HUE031449T2 (en) 2017-07-28
CA2693801C (en) 2018-08-14
AU2008278969A1 (en) 2009-01-29
CN103467548A (zh) 2013-12-25
CN103360445B (zh) 2016-05-18
CN101778858A (zh) 2010-07-14
JP2018104449A (ja) 2018-07-05
BRPI0814318B1 (pt) 2021-04-06
CN103360446A (zh) 2013-10-23
JP2014088394A (ja) 2014-05-15
JP5925989B2 (ja) 2016-05-25
JP2016147858A (ja) 2016-08-18
JP6343624B2 (ja) 2018-06-13
TW200918547A (en) 2009-05-01
AU2008278969B2 (en) 2011-11-17
CN103360447A (zh) 2013-10-23
WO2009013351A3 (en) 2009-04-02
EP3170833B1 (en) 2020-05-20
JP2010534635A (ja) 2010-11-11
KR102508115B1 (ko) 2023-03-08
JP2020172516A (ja) 2020-10-22
TWI427083B (zh) 2014-02-21
EP2181117A2 (en) 2010-05-05
ZA201000188B (en) 2010-09-29
ES2805534T3 (es) 2021-02-12
EP2181117B1 (en) 2016-11-09
BRPI0814318A2 (pt) 2015-01-06
JP2018109020A (ja) 2018-07-12
RU2476438C2 (ru) 2013-02-27
RU2010107057A (ru) 2011-09-10
KR20160003899A (ko) 2016-01-11

Similar Documents

Publication Publication Date Title
CN101778858B (zh) 大环内酯固态晶型
US8518900B2 (en) Macrolide synthesis process and solid-state forms
SI22888A (sl) Polimorfi donepezil hidroklorida in postopek izdelave
SI9720038A (sl) Polimorfi donepezil hidroklorida in postopek izdelave
EP2646457B1 (en) Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
KR100431431B1 (ko) 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
EP2855499A1 (en) Solid state forms of fidaxomycin and processes for preparation thereof
US8722863B2 (en) Solid state forms of fidaxomycin and processes for preparation thereof
CN113583050B (zh) 替诺福韦磷酸酯a晶型及其制备和应用
CN114105948A (zh) 一种曲格列汀杂质化合物
TW202333694A (zh) 稠環衍生物的晶型、其製備方法及其應用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant